Literature DB >> 26363505

Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators.

Atul D Jain1, Haranatha Potteti2, Benjamin G Richardson1, Laura Kingsley3, Julia P Luciano4, Aya F Ryuzoji4, Hyun Lee1, Aleksej Krunic1, Andrew D Mesecar5, Sekhar P Reddy6, Terry W Moore7.   

Abstract

Activation of the transcription factor Nrf2 has been posited to be a promising therapeutic strategy in a number of inflammatory and oxidative n class="Disease">stress diseases due to its regulation of detoxifying enzymes. In this work, we have developed a comprehensive structure-activity relationship around a known, naphthalene-based non-electrophilic activator of Nrf2, and we report highly potent non-electrophilic activators of Nrf2. Computational docking analysis of a subset of the compound series demonstrates the importance of water molecule displacement for affinity, and the X-ray structure of di-amide 12e supports the computational analysis. One of the best compounds, acid 16b, has an IC50 of 61 nM in a fluorescence anisotropy assay and a Kd of 120 nM in a surface plasmon resonance assay. Additionally, we demonstrate that the ethyl ester of 16b is an efficacious inducer of Nrf2 target genes, exhibiting ex vivo efficacy similar to the well-known electrophilic activator, sulforaphane.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cul3; Keap1; Keap1/Nrf2 interaction; Nrf2; Protein–protein interaction; Transcription factor

Mesh:

Substances:

Year:  2015        PMID: 26363505      PMCID: PMC4600463          DOI: 10.1016/j.ejmech.2015.08.049

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  51 in total

1.  Ligand efficiency: a useful metric for lead selection.

Authors:  Andrew L Hopkins; Colin R Groom; Alexander Alex
Journal:  Drug Discov Today       Date:  2004-05-15       Impact factor: 7.851

2.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

4.  Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.

Authors:  Shih-Ching Lo; Xuchu Li; Michael T Henzl; Lesa J Beamer; Mark Hannink
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

5.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

Review 6.  Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.

Authors:  Akhileshwar Namani; Yulong Li; Xiu Jun Wang; Xiuwen Tang
Journal:  Biochim Biophys Acta       Date:  2014-05-20

Review 7.  Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.

Authors:  B G Richardson; A D Jain; T E Speltz; T W Moore
Journal:  Bioorg Med Chem Lett       Date:  2015-04-16       Impact factor: 2.823

8.  Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3.

Authors:  Ling Gao; Jiakun Wang; Konjeti R Sekhar; Huiyong Yin; Nicholas F Yared; Scott N Schneider; Soumya Sasi; Timothy P Dalton; Mark E Anderson; Jefferson Y Chan; Jason D Morrow; Michael L Freeman
Journal:  J Biol Chem       Date:  2006-11-25       Impact factor: 5.157

9.  Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism.

Authors:  Douglas Marcotte; Weike Zeng; Jean-Christophe Hus; Andres McKenzie; Cathy Hession; Ping Jin; Chris Bergeron; Alexey Lugovskoy; Istvan Enyedy; Hernan Cuervo; Deping Wang; Cédric Atmanene; Dominique Roecklin; Malgorzata Vecchi; Valérie Vivat; Joachim Kraemer; Dirk Winkler; Victor Hong; Jianhua Chao; Matvey Lukashev; Laura Silvian
Journal:  Bioorg Med Chem       Date:  2013-04-19       Impact factor: 3.641

Review 10.  The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer.

Authors:  Emilia Kansanen; Suvi M Kuosmanen; Hanna Leinonen; Anna-Liisa Levonen
Journal:  Redox Biol       Date:  2013-01-18       Impact factor: 11.799

View more
  30 in total

Review 1.  Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function.

Authors:  Chunlin Zhuang; Zhongli Wu; Chengguo Xing; Zhenyuan Miao
Journal:  Medchemcomm       Date:  2016-11-17       Impact factor: 3.597

2.  Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).

Authors:  Mengqi Zhong; Andrew Lynch; Samantha N Muellers; Stefan Jehle; Lingqi Luo; David R Hall; Reina Iwase; James P Carolan; Megan Egbert; Amanda Wakefield; Kristina Streu; Christine M Harvey; Paula C Ortet; Dima Kozakov; Sandor Vajda; Karen N Allen; Adrian Whitty
Journal:  Biochemistry       Date:  2020-01-02       Impact factor: 3.162

3.  Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis.

Authors:  Youbo Zhang; Tingting Yan; Dongxue Sun; Cen Xie; Tianxia Wang; Xiaoyan Liu; Jing Wang; Qiong Wang; Yuhong Luo; Ping Wang; Tomoki Yagai; Kristopher W Krausz; Xiuwei Yang; Frank J Gonzalez
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

4.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

5.  Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability.

Authors:  Phillip R Lazzara; Brian P David; Aparna Ankireddy; Benjamin G Richardson; Katherine Dye; Kiira M Ratia; Sekhar P Reddy; Terry W Moore
Journal:  J Med Chem       Date:  2019-11-14       Impact factor: 7.446

6.  Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction.

Authors:  Jesus M Ontoria; Ilaria Biancofiore; Paola Fezzardi; Federica Ferrigno; Esther Torrente; Stefania Colarusso; Elisabetta Bianchi; Matteo Andreini; Alexandros Patsilinakos; Georg Kempf; Martin Augustin; Stefan Steinbacher; Vincenzo Summa; Robert Pacifici; Ignacio Muñoz-Sanjuan; Larry Park; Alberto Bresciani; Celia Dominguez; Leticia Toledo Sherman; Steven Harper
Journal:  ACS Med Chem Lett       Date:  2020-04-03       Impact factor: 4.345

7.  Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors.

Authors:  Benjamin G Richardson; Atul D Jain; Haranatha R Potteti; Phillip R Lazzara; Brian P David; Chandra R Tamatam; Ewelina Choma; Kornelia Skowron; Katherine Dye; Zamia Siddiqui; Yue-Ting Wang; Aleksej Krunic; Sekhar P Reddy; Terry W Moore
Journal:  J Med Chem       Date:  2018-08-31       Impact factor: 7.446

8.  Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors.

Authors:  Phillip R Lazzara; Atul D Jain; Amanda C Maldonado; Benjamin Richardson; Kornelia J Skowron; Brian P David; Zamia Siddiqui; Kiira M Ratia; Terry W Moore
Journal:  ACS Med Chem Lett       Date:  2020-02-19       Impact factor: 4.345

9.  Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors.

Authors:  Meng-Chen Lu; Shi-Jie Tan; Jian-Ai Ji; Zhi-Yun Chen; Zhen-Wei Yuan; Qi-Dong You; Zheng-Yu Jiang
Journal:  ACS Med Chem Lett       Date:  2016-07-05       Impact factor: 4.345

10.  Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction.

Authors:  Sumi Lee; Longqin Hu
Journal:  Med Chem Res       Date:  2020-04-10       Impact factor: 1.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.